Litalir
Litalir is a medicine authorised by Swissmedic under authorisation number 52958. The authorisation holder is Cheplapharm Schweiz GmbH. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 27 April 1995 and the authorisation is valid without a time limit. ATC code L01XX05 places the medicine in the group Antineoplastic agents.
| Authorisation number | 52958 |
|---|---|
| Name | Litalir |
| Full name | Litalir, Hartkapseln |
| Authorisation holder | Cheplapharm Schweiz GmbH |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L01XX05 |
| First authorisation | 27 April 1995 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Litalir, Hartkapseln | A | 27 April 1995 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 16 | 100 | Kapsel(n) | L01XX05 | 07.16.1. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Litalir authorised in Switzerland?
Yes. Litalir is authorised by Swissmedic under authorisation number 52958, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Litalir have?
Litalir is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Litalir?
The authorisation holder is Cheplapharm Schweiz GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.